We are pleased to introduce the collection Model Organisms in Neuropharmacology.
Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. This article collection will showcase studies of Model Organisms that have significance to the field of Neuropharmacology as a whole.
Classically used for biomedical studies, model organisms are progressively entering many disciplines within the Neuropharmacology field.
Manuscripts submitted to the collection could, but are not limited to, exploring the following areas:
1. Neurotoxiocological screening
2. Neurological disease modelling
3. Use of animal models in translational research
4. Comparative and analytical studies regarding the cellular and molecular biology of drug targets through to their roles in whole organisms.
5. The use of model organisms in either pre-clinical or clinical research to elucidate basic neuropharmacological mechanisms in health and disease.
6. Limitations of model organisms in research.
We are pleased to introduce the collection Model Organisms in Neuropharmacology.
Model organisms represent an invaluable resource for fundamental and applied research, allowing prediction studies, modeling, and the identification of action mechanisms. This article collection will showcase studies of Model Organisms that have significance to the field of Neuropharmacology as a whole.
Classically used for biomedical studies, model organisms are progressively entering many disciplines within the Neuropharmacology field.
Manuscripts submitted to the collection could, but are not limited to, exploring the following areas:
1. Neurotoxiocological screening
2. Neurological disease modelling
3. Use of animal models in translational research
4. Comparative and analytical studies regarding the cellular and molecular biology of drug targets through to their roles in whole organisms.
5. The use of model organisms in either pre-clinical or clinical research to elucidate basic neuropharmacological mechanisms in health and disease.
6. Limitations of model organisms in research.
